No Data
No Data
Unusual Options Activity: CCJ, WBD and Others Attract Market Bets
EST May 22nd Morning Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.
AstraZeneca plans to nearly double sales to $80 billion by 2030
British pharmaceutical giant AstraZeneca said on Tuesday that its goal is to reach 80 billion US dollars in sales by 2030, nearly double the 45.8 billion US dollars in 2023. The company said it plans to launch 20 new drugs by 2030 to meet new gross revenue targets. Earlier, investment bank Jefferies (Jefferies) predicted that by 2031, AstraZeneca's annual sales would exceed 70 billion US dollars. Astra set this goal ahead of its first Investor Day event in 10 years. The company's CEO Suboke (Suboco) said he wants AstraZeneca to compete fiercely
Jefferies Financial Group Inc's Dividend Analysis
Zealand Pharma Shares Attractive Ahead of Key Obesity Drug Data -- Market Talk
0901 GMT - Zealand Pharma's apparent share selloff on competitor data is an opportunity, in Jefferies's view. Zealand Pharma has a pipeline of obesity drugs and shares have risen 66% this year, but th
Jefferies Financial Group Insider Sold Shares Worth $12,974,358, According to a Recent SEC Filing
Brian P Friedman, Director, President, on May 13, 2024, sold 280,396 shares in Jefferies Financial Group (JEF) for $12,974,358. Following the Form 4 filing with the SEC, Friedman has control over a to
Jefferies Financial(JEF.US) Officer Sells US$12.97 Million in Common Stock
$Jefferies Financial(JEF.US)$ Officer FRIEDMAN BRIAN P sold 280.4K shares of common stock on May 13, 14, 2024 at an average price of $46.2716 for a total value of $12.97 million.Source: Announcement W
No Data
affable Blobfish_403 : 正常情况下,这些通胀数据应该会继续上涨。
YZRolling affable Blobfish_403: